CE Mark Granted to Roche's New Hep C Tests
Indicative of its compliance with Europe's standards, Roche's tests to confirm Hepatitis C infection and predict treatment response have been acknowledged by the EU.
Continue reading »Indicative of its compliance with Europe's standards, Roche's tests to confirm Hepatitis C infection and predict treatment response have been acknowledged by the EU.
Continue reading »New research demonstrates how Hepatitis C hijacks a specific, microRNA molecule. The study clarifies why an experimental antiviral drug that binds to this microRNA molecule effectively targets the Hepatitis C virus.
Continue reading »Find out about the prevalence, signs and symptoms and treatment for autoimmune hepatitis.
Continue reading »Six months after Incivek and Victrelis were approved by the FDA for Hepatitis C, a LaunchTrends® report indicates that triple therapy with these drugs is the new standard of care for treating genotype 1 Hepatitis C.
Continue reading »When under stress, some people grind their teeth. Though, there are several more reasons those with Hep C are vulnerable to and more prone to complications of teeth grinding.
Continue reading »Two Hepatitis C Phase 1 studies are set to evaluate the safety and tolerability of NS5B polymerase inhibitors from Vertex and Alios BioPharma.
Continue reading »A recently presented study further confirms the association between Hepatitis C infection and coronary artery disease.
Continue reading »Learn about the new research indicating that green tea could prevent the recurrence of Hepatitis C after a liver transplant.
Continue reading »Achillion's Phase 1b Hepatitis C trial for ACH-2928, their first generation inhibitor of the NS5A protein, posted good antiviral activity, safety and tolerability results after just three days.
Continue reading »OraSure's rapid Hepatitis C blood test can turn out results in just 20 minutes - a convenience that has earned it a waiver to increase its availability.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window